For 25 years ABR, Inc. (American BioResearch) has served the global pharmaceutical and biotechnology industries with world-class quality assurance and industry-leading turnaround time. The team of scientists at ABR is dedicated to providing accurate, timely, and precise results, while ensuring a high degree of customer service. In addition, ABR continues to design and develop virus detection protocols to meet evolving needs and changing regulations.
ABR’s standard assays satisfy United States 9th Code of Federal Regulation (9CFR), European Medicines Agency (EMEA), CVMP and CPMP regulations. Additionally, ABR operates under Good Laboratory Practice (GLP) as defined in the Twenty-first Code of Federal Regulations (21CFR), Part 58. ABR has the capability to customize studies for clients needs in ever changing regulatory environments.
)